Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2017
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trialsD Arnold, B Lueza, J-Y Douillard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumorsB Markman, J Tabernero, I Krop, et al.
ESMO Open|December 1, 2024
A phase I dose-escalation study of LRP5/6 antagonist BI 905677 in patients with advanced solid tumorsH-J Lenz, G Argilés, M J A de Jonge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2020
Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancerG Serna, F Ruiz-Pace, J Hernando, et al.
Actas Urologicas Espanolas|November 6, 2017
Cognitive function in patients on androgen suppression: A prospective, multicentric studyJ Morote, Á J Tabernero, J L Álvarez-Ossorio, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trialS Kasper, E Elez, U Neumann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2022
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation studyA Gazzah, P L Bedard, C Hierro, et al.
ESMO Open|December 1, 2016
ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answersN I Cherny, R Sullivan, U Dafni, et al.
Forensic Science International|May 13, 2025
Impact of coca leaf flour candy consumption on cocaine and benzoylecgonine levels: The role of hygrine and cuscohygrine in distinguishing licit from illicit cocaine useN C Rubio, P Herbello-Hermelo, I Álvarez-Freire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation studyJ Tabernero, F Ciardiello, F Rivera, et al.
Pageof 18